Wellness companies eager to avoid WeightWatchers’ fate embrace weight-loss drugs
NEW YORK (Reuters) -Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the fate of WeightWatchers, which declared bankruptcy this week, citing vastly increased use of the new blockbuster medicines.
Read More from the Global Wellness News ™